PDS Biotechnology (PDSB) Acquisitions (2019)
PDS Biotechnology's (PDSB) quarterly Acquisitions came in at $1.0 in Q4 2019, down 100.0% on a QoQ basis from $29.1 million in Q1 2019.
PDS Biotechnology (PDSB) Acquisitions (2019) Analysis & Trends
PDS Biotechnology (PDSB) has 1 years of Acquisitions data on file, last reported at $1.0 in Q4 2019.
- Quarterly Acquisitions changed N/A year-over-year to $1.0 in Q4 2019, while the trailing twelve-month figure through Sep 2020 was $1.0 (down 100.0% YoY) and the FY2019 annual result came in at $29.1 million, changed N/A from the prior year.
- Acquisitions slipped to $1.0 in Q4 2019, from $29.1 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $29.1 million in Q1 2019 to a low of $1.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | PDS Biotechnology | 11.58 Mn | 11.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1.00 |
| Mar 31, 2019 | 29.11 Mn |